Antimicrobial products in the 21st century: optimal use and clinical development
2006
Lloyd, Reeve-Johnson
The success or failure in the marketplace of a novel antimicrobial product represents a financial risk on the part of a pharmaceutical company that is underpinned by the rationale of a scientific approach to its development. There are a variety of financial, marketing and pharmacological models that can be used to make predictive assessments of likely product success and the financial implications. The paper discusses development and use of antimicrobials and proffers suggestions of what constitutes optimal use by veterinary practitioners who through their role as dispensers of prescription products are by default the gatekeepers to the animal health market and share responsibility for the financial success or failure of veterinary products.
显示更多 [+] 显示较少 [-]